Drug intelligence / Profile preview

AmnioFix Sports Med

Development stage
Unknown
Lead developer
MIMEDX
Administration
Intralesional
01

Overview

AmnioFix Sports Med is a human amniotic membrane allograft biologic developed by MiMedx Group, Inc. It is composed of dehydrated human amnion/chorion membrane (dHACM) derived from placental tissue donated by healthy mothers undergoing cesarean sections. The product is processed using the proprietary PURION Process, which involves cleansing, dehydration, and electron-beam sterilization to preserve the natural collagen matrix and bioactive properties while ensuring safety. AmnioFix Sports Med contains over 200 growth factors, specialized cytokines, and enzyme inhibitors that work synergistically to modulate inflammation, reduce scar tissue formation, and enhance the healing of damaged soft tissues. It is primarily administered via injection for various musculoskeletal and sports-related conditions, including plantar fasciitis and Achilles tendinitis.

Brand names
AmnioFix Sports MedAmnioFix
Other names
dehydrated human amnion/chorion membranedHACM
02

Targets

VEGFA (Vascular endothelial growth factor A)TGFB (GARP–latent transforming growth factor beta 1 complex)FGF (Fibroblast growth factor 6)PDGF (Platelet-derived Growth Factor family)

Beyond the preview

Go deeper on AmnioFix Sports Med.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AmnioFix Sports Med.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call